Announcement under Regulation 30 (LODR)-Change in Management
Filed with BSE · · 5 pages · English
rd the members of the Company, at the Thirty-Third (33 ) Annual General Meeting (the Meeting) held on Friday, September 26, 2025, based on the recommendation of the Board of Directors, have approved the following resolutions: a) Re-appointment of Mr. Naresh Kumar Singla (DIN 00027448) as Managing Director of the Company for further term of Five years beginning from 1st April, 2026 to 31st March, 2
Earlier from Titan Biotech
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
- Titan Biotech Limited Press Release Sep 26 2025
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Titan Biotech Limited Press Release Sep 24 2025
Later from Titan Biotech
- Titan Biotech Limited Press Release Sep 29 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Titan Biotech Limited Press Release Oct 09 2025
- Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.
- Titan Biotech Limited Press Release Nov 04 2025
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech